Jeanette Acosta Invest in Women’s Health Act of 2024
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Jeanette Acosta Invest in Women’s Health Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing women's health issues. Although the official summary and full text of the bill are not provided, the bill's title suggests a focus on increasing investment or resources dedicated to women's health. As of December 4, 2024, the bill was referred to the House Committee on Energy and Commerce but ultimately failed or expired without further legislative action.
This bill sought to enhance investment in women's health but did not advance beyond committee referral and expired without passage in the 118th Congress.
- The bill is titled the Jeanette Acosta Invest in Women’s Health Act of 2024, indicating a focus on women's health investment.
- It was introduced in the House of Representatives during the 118th Congress.
- The latest recorded action was referral to the House Committee on Energy and Commerce on December 4, 2024.
- The bill status is marked as failed or expired, indicating no enactment into law.
- No official summary or full bill text is available to provide detailed provisions or funding mechanisms.
['Women potentially benefiting from increased health investments', "Health agencies involved in women's health programs", "Healthcare providers specializing in women's health"]
['Lack of available bill text limits understanding of specific implementation requirements or funding sources', 'No information on oversight or enforcement mechanisms', 'Potential cost implications are unknown due to absence of detailed provisions', 'Unclear authority or scope of the bill without full text']
The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce, a common committee for health-related legislation. Its failure to progress beyond committee referral suggests limited legislative momentum or prioritization during this session. The absence of a summary or text in the public record limits detailed contextual analysis.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["If enacted, the bill could lead to increased federal investment in women's health programs, potentially improving health outcomes.", "Enhanced focus on women's health might influence related healthcare services and research priorities.", "Failure to pass may delay or reduce attention to women's health funding in the near term."]
The absence of an official summary and full bill text significantly limits transparency and public understanding of the bill’s specific goals, provisions, and fiscal impacts. This lack of information complicates oversight and informed debate. Additionally, the bill’s failure to advance beyond committee referral highlights the importance of tracking legislative progress to assess policy impact.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.